23andMe is in trouble. What happens to all the DNA data?
Sep 25, 2024 · Once a hot $6 billion biotech company, 23andMe is now on the verge of collapse. What could happen to the DNA data of its 14 million customers? AILSA CHANG, HOST: The genetic testing company...
23andMe cuts 40% of its workforce, discontinues all therapy …
Nov 11, 2024 · Genetic testing firm 23andMe said on Monday it is reducing about 40%, or 200 employees, from its workforce and discontinuing further development of all its therapies as part of a restructuring...
What happened to 23andMe? | CNN Business
Sep 20, 2024 · 23andMe has tried to convert one-time buyers into subscribers with the promise of continued feedback and personalized wellness plans. But, as the Wall Street Journal wrote in January, the company...
23andMe is on the verge of bankruptcy. It may be too late to …
Oct 16, 2024 · Popular genetic testing company 23andMe is facing bankruptcy and may sell the genetic data of its 15 million customers. Users have the option to delete their data, but the company can retain it for three years. Data that's already been sold to researchers may not be able to be deleted. What's next?
23andMe is exploring strategic alternatives, looking to raise capital
Jan 28, 2025 · 23andMe said it's started exploring strategic alternatives, including a possible sale.
What happens to all of 23andMe's genetic DNA data? : NPR
Oct 3, 2024 · According to 23andMe’s transparency report, authorities have sought genetic data on 15 individuals since 2015, but the company has resisted the requests and never produced data for...
23andMe Is Sinking Fast. Can the Company Survive? | WIRED
Oct 1, 2024 · Valued at $6 billion when it went public in 2021, 23andMe’s stock has plummeted from $10 a share three years ago. The company has yet to turn a profit in the 18 years since its founding. Now, it...
23andMe directors resign as the CEO of the ... - Associated Press News
Sep 19, 2024 · NEW YORK (AP) — All of 23andMe’s independent directors resigned from its board this week, a rare move that marks the latest challenge for the genetic-testing company. The resignations follow drawn-out negotiations with 23andMe CEO and co-founder Anne Wojcicki, who wants to take the company private.
23andMe weighing up sale of the company as cash runs dry
Jan 29, 2025 · 23andMe is considering a sale of the company as it weighs up strategic options, capping a torrid year for the genetic testing business. A special committee of its directors’ board is considering ...
As 23andMe Struggles, Concerns Surface About Its Genetic Data
Oct 5, 2024 · The genetic testing company 23andMe, once valued at $6 billion, is facing an uncertain future after a drop in share prices, a recent board resignation and a data breach last year that affected...